Natoli said that this acquisition will expand the company’s refurbishment services and enable it to provide its customers with a wider range of custom encapsulation solutions.
Photo © iStockphoto.com/StudioThreeDots
Tablet compression parts and services specialist Natoli Engineering Company, Inc. (St. Charles, MO), has acquired Carlisle Precision Machining (CPM; Nampa, ID), a company that specializes in aftermarket change and spare parts for Bosch-type encapsulation machines used in the pharmaceutical and nutraceutical industries. As a subsidiary of Natoli, CPM has been renamed Carlisle Precision Encapsulation Parts.
In a press statement from Natoli, the company said that this acquisition will expand the company’s refurbishment services and enable it to provide its customers with a wider range of custom encapsulation solutions. Some of the encapsulation parts manufactured by Carlisle Precision Encapsulation Parts include dosing disks, segments, alignment pins, sorting blocks, and magazine assemblies. The company said that Carlisle Precision Encapsulation Parts also offers training and consulting services.
Dale Natoli, president, Natoli, commented on the acquisition in the press statement: “We are very excited to have Carlisle as part of the Natoli family of companies. We look forward to bringing the same industry leadership and high level of customer service to the encapsulation machine replacement parts market as we have supplied to the tablet tooling industry for many years.”
In addition to tablet compression, Natoli also offers tablet press replacement parts, tooling and press refurbishing services, analytical inspection equipment, technical training courses, and tablet compression accessories. In addition, Natoli offers AIM Data Acquisition and Analytical Software for tablet and capsule research, development, and manufacturing.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.